Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Forma Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Forma Therapeutics Raises US$10 Million In Venture Financing 11
Partnerships 12
Ubiquigent Enters into Development Agreement with Forma Therapeutics 12
Forma Therapeutics Enters into Agreement with Arpeggio Biosciences 13
Celgene Enters into Agreement with Forma Therapeutics 14
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 15
Forma Therapeutics Expands Discovery Agreement with Cancer Research Technology 16
Forma Therapeutics Partners With Celgene 17
Forma Therapeutics Enters Into Agreement With Celgene 18
Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 20
FORMA Therapeutics Enters Into Co-Development Agreement With Janssen Biotech 21
FORMA Therapeutics Enters Into R&D Agreement With Boehringer Ingelheim 22
Licensing Agreements 23
Forma Therapeutics and HitGen Enter into Licensing Agreement 23
Forma Therapeutics Enters into Licensing Agreement with University of Oxford 24
Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 25
Janssen Biotech Exercises Option For Licensing Agreement With Forma Therapeutics 26
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27
Forma Therapeutics Inc – Key Competitors 28
Forma Therapeutics Inc – Key Employees 29
Forma Therapeutics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Corporate Communications 31
Apr 09, 2018: FORMA Therapeutics Appoints Tim Clackson As Board Director 31
Nov 14, 2017: FORMA Therapeutics Appoints Christine Bellon, Ph.D., J.D., General Counsel and Corporate Secretary 32
Government and Public Interest 33
Feb 21, 2017: FORMA Therapeutics Awarded Grant from Michael J. Fox Foundation for Parkinson’s Research 33
Product News 34
Apr 05, 2018: FORMA Therapeutics Achieves Key Objective in Collaboration with Celgene to Advance a Novel Protein Homeostasis Oncology/Immuno-Oncology Program 34
Other Significant Developments 35
Mar 13, 2017: FORMA Therapeutics Announces Achievement of First Clinical Development Milestone in Partnership with Boehringer Ingelheim 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Forma Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Forma Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Forma Therapeutics Raises US$10 Million In Venture Financing 11
Ubiquigent Enters into Development Agreement with Forma Therapeutics 12
Forma Therapeutics Enters into Agreement with Arpeggio Biosciences 13
Celgene Enters into Agreement with Forma Therapeutics 14
ZoBio and Domainex Enter into Agreement with Forma Therapeutics 15
Forma Therapeutics Expands Discovery Agreement with Cancer Research Technology 16
Forma Therapeutics Partners With Celgene 17
Forma Therapeutics Enters Into Agreement With Celgene 18
Forma Therapeutics Enters Into Co-Development Agreement With TGen Drug Development 20
FORMA Therapeutics Enters Into Co-Development Agreement With Janssen Biotech 21
FORMA Therapeutics Enters Into R&D Agreement With Boehringer Ingelheim 22
Forma Therapeutics and HitGen Enter into Licensing Agreement 23
Forma Therapeutics Enters into Licensing Agreement with University of Oxford 24
Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 25
Janssen Biotech Exercises Option For Licensing Agreement With Forma Therapeutics 26
Moffitt Cancer Center Enters into Option for Licensing Agreement with Forma Therapeutics 27
Forma Therapeutics Inc, Key Competitors 28
Forma Therapeutics Inc, Key Employees 29
Forma Therapeutics Inc, Other Locations 30
List of Figures
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Forma Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8